Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
GHRP-2 and GHRP-6: Selectivity Comparison This table illustrates why ipamorelin has become the preferred GHRP for researchers where hormonal specificity and clean pharmacology are experimental priorities delivering comparable GH release potency to GHRP-6 while eliminating the ACTH and cortisol confounders that complicate interpretation of results with the older compounds
A dose-dependent superiority in lowering HbA 1c was evident with all three tirzepatide doses vs all comparators, with mean differences ranging from 17.71 mmol/mol (1.62%) to 22.35 mmol/mol (2.06%) vs placebo, 3.22 mmol/mol (0.29%) to 10.06 mmol/mol (0.92%) vs GLP-1 RAs, and 7.66 mmol/mol (0.70%) to 12.02 mmol/mol (1.09%) vs basal insulin regimens
It is paramount to understand the difference between pharmaceutical-grade and research-grade peptides
Not recommended for children or breast feeding women (141mg per 100ml) DIRECTIONS Please refer to packaging for directions of use SAFETY WARNING For allergens, including cereals containing gluten see ingredients in bold
No controlled human-lifespan evidence exists
Mithieux 2005
US$ 24.39
US$ 28.38
US$ 25.59
US$ 28.29
US$ 23.57
US$ 28.52
US$ 20.90
US$ 26.94
US$ 25.63
US$ 29.07
US$ 28.90
US$ 27.67
US$ 23.05
US$ 24.21
